Haleon PLC Sponsored ADR $HLN Shares Bought by PDS Planning Inc

PDS Planning Inc boosted its stake in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 17.5% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 25,441 shares of the company’s stock after purchasing an additional 3,796 shares during the quarter. PDS Planning Inc’s holdings in Haleon were worth $264,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Hanson & Doremus Investment Management grew its position in Haleon by 234.1% during the second quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company’s stock worth $25,000 after buying an additional 1,662 shares during the period. Bartlett & CO. Wealth Management LLC grew its position in shares of Haleon by 135.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company’s stock valued at $27,000 after purchasing an additional 1,491 shares during the last quarter. Banque Transatlantique SA acquired a new stake in shares of Haleon in the first quarter valued at approximately $27,000. Opal Wealth Advisors LLC acquired a new stake in shares of Haleon in the first quarter valued at approximately $29,000. Finally, Ransom Advisory Ltd acquired a new stake in shares of Haleon in the first quarter valued at approximately $31,000. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Stock Performance

NYSE:HLN opened at $8.99 on Monday. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48. The company has a market cap of $40.01 billion, a P/E ratio of 23.04, a P/E/G ratio of 2.64 and a beta of 0.20. Haleon PLC Sponsored ADR has a fifty-two week low of $8.71 and a fifty-two week high of $11.42. The firm’s 50 day moving average is $9.42 and its two-hundred day moving average is $10.02.

Haleon Increases Dividend

The business also recently declared a semi-annual dividend, which was paid on Thursday, September 18th. Shareholders of record on Friday, August 15th were paid a dividend of $0.0555 per share. This is an increase from Haleon’s previous semi-annual dividend of $0.05. This represents a yield of 190.0%. The ex-dividend date of this dividend was Friday, August 15th. Haleon’s payout ratio is 28.21%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on HLN. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a research report on Wednesday, October 8th. Barclays lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, September 16th. The Goldman Sachs Group upgraded shares of Haleon from a “neutral” rating to a “buy” rating in a research report on Wednesday, September 10th. Finally, Wall Street Zen downgraded shares of Haleon from a “buy” rating to a “hold” rating in a research note on Saturday, July 12th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Haleon has an average rating of “Moderate Buy” and an average price target of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.